OmicLab Limited is a high-tech enterprise dedicated to precision medicine, integrating bioinformatics and machine learning technology development, multi-omics data analysis, and customised genetic testing. The company is committed to building a digital analysis and testing platform with advanced bioinformatics technology, machine learning, and sequencing techniques to promote research in the field of life and health and the translation of industry-academia-research. We provide customers with reliable and precise medical services and solutions.

Relying on leading technology and a complete multi-omics data analysis chain, the company launched the CombCure precision cancer diagnosis and treatment platform to offer digital detection solutions for hospitals and clinical testing institutions to provide patients with faster and safer precision treatment solutions. In the future, OmicLab Limited will offer more advanced digital platform solutions with better services and contribute to the goal of utilising gene technology to benefit human health.